Cargando…
OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767553/ http://dx.doi.org/10.1186/1742-4690-6-S3-O31 |
| _version_ | 1782173320899198976 |
|---|---|
| author | Vasan, S Hurley, A Schlesinger, SJ Hannaman, D Gardiner, DF Dugin, DP Boente-Carrera, MM Vittorino, RM Caskey, M Andersen, J Huang, Y Cox, J Tarragona, T Gill, DK Cheeseman, H Clark, L Dally, L Smith, C Schmidt, C Park, H Sayeed, E Gilmour, J Fast, P Bernard, R Ho, DD |
| author_facet | Vasan, S Hurley, A Schlesinger, SJ Hannaman, D Gardiner, DF Dugin, DP Boente-Carrera, MM Vittorino, RM Caskey, M Andersen, J Huang, Y Cox, J Tarragona, T Gill, DK Cheeseman, H Clark, L Dally, L Smith, C Schmidt, C Park, H Sayeed, E Gilmour, J Fast, P Bernard, R Ho, DD |
| author_sort | Vasan, S |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2767553 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27675532009-10-28 OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers Vasan, S Hurley, A Schlesinger, SJ Hannaman, D Gardiner, DF Dugin, DP Boente-Carrera, MM Vittorino, RM Caskey, M Andersen, J Huang, Y Cox, J Tarragona, T Gill, DK Cheeseman, H Clark, L Dally, L Smith, C Schmidt, C Park, H Sayeed, E Gilmour, J Fast, P Bernard, R Ho, DD Retrovirology Oral Presentation BioMed Central 2009-10-22 /pmc/articles/PMC2767553/ http://dx.doi.org/10.1186/1742-4690-6-S3-O31 Text en Copyright © 2009 Vasan et al; licensee BioMed Central Ltd. |
| spellingShingle | Oral Presentation Vasan, S Hurley, A Schlesinger, SJ Hannaman, D Gardiner, DF Dugin, DP Boente-Carrera, MM Vittorino, RM Caskey, M Andersen, J Huang, Y Cox, J Tarragona, T Gill, DK Cheeseman, H Clark, L Dally, L Smith, C Schmidt, C Park, H Sayeed, E Gilmour, J Fast, P Bernard, R Ho, DD OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers |
| title | OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers |
| title_full | OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers |
| title_fullStr | OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers |
| title_full_unstemmed | OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers |
| title_short | OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers |
| title_sort | oa05-01. in vivo electroporation enhances the immunogenicity of advax, a dna-based hiv-1 vaccine candidate, in healthy volunteers |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767553/ http://dx.doi.org/10.1186/1742-4690-6-S3-O31 |
| work_keys_str_mv | AT vasans oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT hurleya oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT schlesingersj oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT hannamand oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT gardinerdf oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT dugindp oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT boentecarreramm oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT vittorinorm oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT caskeym oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT andersenj oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT huangy oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT coxj oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT tarragonat oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT gilldk oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT cheesemanh oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT clarkl oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT dallyl oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT smithc oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT schmidtc oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT parkh oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT sayeede oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT gilmourj oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT fastp oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT bernardr oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers AT hodd oa0501invivoelectroporationenhancestheimmunogenicityofadvaxadnabasedhiv1vaccinecandidateinhealthyvolunteers |